Global Interventional Oncology Market - (By Therapy - Radiation Therapy, Particle Embolization & Ablation; By Region- North America, Europe & Asia Pacific) Market Outlook 2024

Abstract
Interventional oncology is a rapidly growing field of interventional oncology which deals with diagnosis and treatment of cancer using minimally invasive procedures. It uses various imaging techniques such as x-ray, ultrasound, computed tomography, or magnetic resonance imaging for guidance purposes. Interventional oncology is general employed for treatment of liver cancer, lung cancer, bone cancer, kidney cancer, prostate cancer, breast cancer, and pancreatic cancer. Interventional oncology treatment market is segmented into Radiation therapy, Ablation, and Particle embolization on the basis of procedure.

Interventional oncology is expected to become the fourth pillar of cancer care, with medical, surgical, and radiation oncology. It provides with minimally invasive treatment option while mitigating various associated risks. Growth of the global interventional oncology market is propelled by rising oncology incidences, growing demand for minimally invasive therapeutics and increasing geriatric population. However, the market faces several challenges due to high treatment cost, associated risk and presence of alternative treatment options.

The report “Global Interventional Oncology Market – (By Therapy – Radiation Therapy, Particle Embolization & Ablation; By Region- North America, Europe & Asia Pacific) Market Outlook 2024” provides in-depth analysis of the current scenario, detailed market outlook of the global interventional oncology market with coverage on major market segments such as Radiation Therapy, Particle Embolization & Ablation. Future forecasts of interventional oncology market overall and across various market segments has been provided in the report till 2024. Furthermore, major industry players have been prudently analysed in the competitive landscape section of the report in order to provide key comparative insights.

Major industry players operating in the global interventional oncology market include Boston Scientific Corporation, Accuray Incorporated, Medtronic PLC, Terumo Corporation, Merit Medical Systems, Inc., BTG PLC, among others. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global interventional oncology market.

Content
1. Executive Summary
2. Research Methodology
3. Interventional Oncology
3.1 Overview
3.2 Applications
3.3 Interventional Oncology Approaches
3.3.1 Diagnostic techniques
3.3.2 Ablation techniques
3.3.3 Embolisation techniques
3.3.4 Palliative techniques
4. Market Analysis
4.1 Market Sizing (Actual & Forecasted)
4.2 Market Share Analysis
4.2.1 Market Share by Segments
4.2.2 Market Share by Region
6. Market Segmentation
6.1 Radiation Therapy
6.1.1 Overview
6.1.2 Market Sizing (Actual & Forecasted)
6.2 Ablation
6.2.1 Overview
6.2.2 Market Sizing (Actual & Forecasted)
6.3 Particle Embolization
6.3.1 Overview
6.3.2 Market Sizing (Actual & Forecasted)
6.3.3 Market Share by Type
8. Regional Analysis
8.1 North America
8.1.1 Market Sizing (Actual & Forecasted)
8.2 Europe
8.2.1 Market Sizing (Actual & Forecasted)
8.3 Asia Pacific
8.3.1 Market Sizing (Actual & Forecasted)
9. Market Dynamics
9.1 Industry Trends & Development
9.1.1 Advent of Personalized Interventional Oncology
9.1.2 Adoption of Artificial Intelligence
9.1.3 Irreversible Electroporation (NanoKnife) Ablation Technique
9.1.4 Adoption of Microwave Ablation (MWA)
9.2 Growth Drivers
9.2.1 Rising Oncology Incidences
9.2.2 Growing Demand for Minimally Invasive Therapeutics
9.2.3 Increasing Geriatric Population
9.3 Challenges
9.3.1 High Treatment Cost
9.3.2 Associated Risks
9.3.3 Alternative Treatment Options
10. Competitive Landscape
10.1 Financial Analysis
10.2 Market Share Analysis
11. Company Profiles
11.1 Boston Scientific Corporation
11.2 Accuray Incorporated
11.4 Medtronic PLC
11.5 Terumo Corporation
11.6 Merit Medical Systems, Inc.
11.7 BTG PLC